|
Market Closed -
Euronext Bruxelles
18:55:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 204.30 EUR | +1.49% |
|
-4.71% | -14.38% |
| 09-30 | Merck's experimental skin disease drug succeeds in mid-stage study | RE |
| 09-29 | UCB Presents Data From Innovative Myasthenia Gravis Portfolio At AANEM Annual Meeting And MGFA Scientific Session | CI |
Transcripts
Search
No results match your criteria
Filters
- Stock Market
- Stocks
- UCB Stock
- News UCB
- Transcripts
Select your edition
All financial news and data tailored to specific country editions


















